comparemela.com

Pharma India News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astrazeneca Pharma India Q4 Results Live : profit rise by 128 61% YOY

Astrazeneca Pharma India Q4 Results Live : Revenue increased by 34.6% YoY & profit increased by 128.61% YoY

Roche Pharma launches multiple sclerosis treatment drug in India

The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).

Astrazeneca Pharma India Q3 FY24 Results Live : profit falls by 46 08% YOY

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.